The AI and quantum technology developer has branhed out as a separate company having secured at least $100m from a range of external investors.

Online banking platform developer Dave has received $100m in convertible note financing from FTX's $2bn corporate venturing vehicle.

The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.

The raw material procurement service has retained almost 75% of financing subsidiary Oxyzo Financial Services following its series A round.

Salesforce Ventures was among the investors in an Insight Partners-led round which helped fund the data orchestration platform developer's purchase of data flow software developer Datakin.

The molecular drug developer received funding from investors including GlaxoSmithKline, MRL Ventures Fund and GV in a Fidelity-led series C round.

SoftBank Vision Fund 2 has led the API marketplace’s latest round at a unicorn valuation, with returning investor M12 also taking part.

The corporate card provider was valued at $2.1bn in a round backed by Stanford University that increased its funding to $380m altogether.

Citi, SVB, State Street and JP Morgan were among the investors that helped the financial software provider boost its valuation to $1.6bn.

Animoca Brands, FTX, Adidas, Alphabet, MoonPay, Genies, Samsung and The Sandbox all took part in the the NFT platform developer's seed round at a $4bn valuation.